Impact of diabetes mellitus on outcome of HCC

被引:37
作者
Amarapurkar, Deepak N. [1 ]
Patel, Nikhil D. [1 ]
Kamani, Praful M. [1 ]
机构
[1] Bombay Hosp & Med Res Ctr, Dept Gastroenterol, Bombay, Maharashtra, India
关键词
hepatocellular carcinoma; diabetes mellitus; non-alcoholic fatty liver disease; chronic liver disease;
D O I
10.1016/S1665-2681(19)31871-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Diabetes mellitus (DM) is recently identified risk factor for development and progression of chronic liver disease as well as hepatocellular carcinoma (HCC). We planned a prospective analysis to identify impact of DM in Indian patients with HCC. Methods: During last 10 years, 160 consecutive patients of HCC were evaluated. Demographic profile like age of presentation, clinical features, etiology of HCC, tumor size at presentation, management and ultimate outcome was compared diabetic with non-diabetic HCC patients. Results: During last 10 years, 160 consecutive patients of HCC were evaluated (Mean age = 59.6 +/- 12.9 years, sex ratio (M: F) = 5.4: 1). Etiology for HCC were hepatitis B in 45 (28.2%), hepatitis C in 18 (11.3%), alcohol in 27 (16.8%), alcohol with hepatitis B in 12 (7.5%), alcohol with hepatitis C in 1 (0.6%), non-alcoholic steatohepatitis in 4 (2.5%) and cryptogenic in 53 (33.2%) patients. Patients of HCC with DM (group-A, n =46, age = 62.6 +/- 9.5 years, sex (M: F) = 6.6:1) were compared with patient of HCC without DM (group-B, n =114, age = 66.7 +/- 13.7 years, sex (M: F) = 5.4:1). Duration of diabetes in group-A was 7.6 +/- 3.2 years. Patients in group-A had more advanced HCC (size of lesion > 5 cm and > 3 lesions of 3 cm or more diameter, portal vein thrombosis or intra-hepatic bile duct involvement) than group-B [34 (73.9%) vs 72 (54.3%)]. Mortality with in one year was significantly more in group-A compared to group-B [36 (78.2 %) vs 56 (49.1 %)]. Conclusion: DM is associated with more advanced lesion and poor outcome in patient with HCC.
引用
收藏
页码:148 / 151
页数:4
相关论文
共 58 条
[1]
Excess risk of primary liver cancer in patients with diabetes mellitus [J].
Adami, HO ;
Chow, WH ;
Nyren, O ;
Berne, C ;
Linet, MS ;
Ekbom, A ;
Wolk, A ;
McLaughlin, JK ;
Fraumeni, JF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20) :1472-1477
[2]
CANCER RISK IN PATIENTS WITH DIABETES-MELLITUS [J].
ADAMI, HO ;
MCLAUGHLIN, J ;
EKBOM, A ;
BERNE, C ;
SILVERMAN, D ;
HACKER, D ;
PERSSON, I .
CANCER CAUSES & CONTROL, 1991, 2 (05) :307-314
[3]
Amarapurkar D, 2002, Trop Gastroenterol, V23, P3
[4]
Hyperinsulinemia predicts fetal liver cancer but is inversely associated with fatal cancer at some other sites -: The Paris Prospective Study [J].
Balkau, B ;
Kahn, HS ;
Courbon, D ;
Eschwège, E ;
Ducimetrière, P .
DIABETES CARE, 2001, 24 (05) :843-849
[5]
Diabetes and hepatocellular carcinoma [J].
Beasley, R. Palmer .
HEPATOLOGY, 2006, 44 (06) :1408-1410
[6]
Insulin resistance in obesity: Metabolic mechanisms and measurement methods [J].
Belfiore, F ;
Iannello, S .
MOLECULAR GENETICS AND METABOLISM, 1998, 65 (02) :121-128
[7]
PROGNOSTIC-SIGNIFICANCE OF DIABETES IN PATIENTS WITH CIRRHOSIS [J].
BIANCHI, G ;
MARCHESINI, G ;
ZOLI, M ;
BUGIANESI, E ;
FABBRI, A ;
PISI, E .
HEPATOLOGY, 1994, 20 (01) :119-125
[8]
Attributable risks for hepatocellular carcinoma in Northern Italy [J].
Braga, C ;
LaVecchia, C ;
Negri, E ;
Franceschi, S .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (04) :629-634
[9]
Nonalcoholic steatohepatitis and hepatocellular carcinoma:: Natural history? [J].
Cotrim, HP ;
Paraná, R ;
Braga, E ;
Lyra, L .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10) :3018-3019
[10]
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study [J].
Davila, JA ;
Morgan, RO ;
Shaib, Y ;
McGlynn, KA ;
El-Serag, HB .
GUT, 2005, 54 (04) :533-539